Int J Biol Sci 17(8):20502068 Bonfioli GB, Rodella L, Metra M, Vizzardi E (2024) GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
CrossRef 8,065 View 287 Download 6 Web of Science Crossref Original Article Alcohol-related liver disease Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 20002021 Pojsakorn Danpanichkul, Luis Antonio Daz, Kanokphong Suparan, Primrose Tothanarungroj, Supapitch Sirimangklanurak, Thanida Auttapracha, Hanna L
10.1056/NEJMoa2206038 40 JensterleM.RizzoM.HaluzkM.JaneA
A single injection of 5 mg or higher (more than double the approved dose) can cause severe nausea, vomiting, and dehydration within hours
The question is not which company has a perfect record, because neither does
What This GLP-1 Cluster Explains Across this series, youll learn: how GLP-1 works within enteroendocrine and gutbrain signaling why microbiome damage weakens GLP-1 sensitivity how stress and cortisol disrupt appetite regulation how SCFAs restore metabolic flexibility what GLP-1 medications cannot biologically repair Whether GLP-1 medications are used or not, long-term metabolic outcomes depend on the same foundation : A stable microbiome that produces adequate SCFAs and supports natural GLP-1 signaling